Reference : Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-year Follow-up of...
Scientific journals : Article
Human health sciences : Surgery
http://hdl.handle.net/2268/129359
Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-year Follow-up of the ATLAS Trial
English
Krämer, Bernhard k []
Klinger, Marian []
Vitko, Stefan []
GLYDA, Maciej []
Midtvedt, Karsten []
Stefoni, Sergio []
Citterio, Franco []
Pietruck, Frank []
SQUIFFLET, Jean-Paul mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
Segoloni, Giuseppe []
Krüger, Bernd []
Sperschneider, Heide []
Banas, Bernhard []
Bäckman, Lars []
Weber, Markus []
Carmellini, Mario []
Perner, Ferenc []
Claesson, Kerstin []
Marcinkowski, Wojciech []
Ostrowski, Marek []
Senatorski, Grzegorz []
Nordström, Johan []
Salmela, Kaija []
15-Sep-2012
Transplantation
Lippincott Williams & Wilkins
94
5
492-498
Yes (verified by ORBi)
0041-1337
1534-6080
Hagerstown
MD
[en] Background. Long-term use of corticosteroids is associated with considerable morbidity, including cardiovascular
and metabolic adverse effects.
Methods. This study evaluated the long-term efficacy and safety of two steroid-free regimens compared with a triple
immunosuppressive therapy in renal transplant recipients. This was a 3-year follow-up to a 6-month, open-label,
randomized, multicenter study.
Results. Data from 3 years were available for 421 (93.3%) of 451 patients in the original intent-to-treat population (143
tacrolimus/basiliximab [Tac/Bas], 139 tacrolimus/mycophenolate mofetil [Tac/MMF], and 139 tacrolimus/MMF/
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/129359

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
00007890-201209150-00011.pdfPublisher postprint263.52 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.